loadpatents
Patent applications and USPTO patent grants for Tebbe; Jan.The latest application filed is for "site specific homogeneous with ksp inhibitors".
Patent | Date |
---|---|
HPPD variants and methods of use Grant 11,371,056 - Linka , et al. June 28, 2 | 2022-06-28 |
Humanized monoclonal antibodies against activated protein c and uses thereof Grant RE49,099 - Zhao , et al. June 7, 2 | 2022-06-07 |
HPPD variants and methods of use Grant 11,180,770 - Linka , et al. November 23, 2 | 2021-11-23 |
Site Specific Homogeneous With Ksp Inhibitors App 20210252161 - LERCHEN; Hans-Georg ;   et al. | 2021-08-19 |
Brain Natriuretic Peptide Engrafted Antibodies App 20210147504 - BROCKSCHNIEDER; Damian ;   et al. | 2021-05-20 |
Atrial Natriuretic Peptide Engrafted Antibodies App 20210139555 - MAYER-BARTSCHMID; Anke ;   et al. | 2021-05-13 |
Site specific homogeneous with KSP inhibitors Grant 10,973,923 - Lerchen , et al. April 13, 2 | 2021-04-13 |
C-type Natriuretic Peptide Engrafted Antibodies App 20210079056 - BROCKSCHNIEDER; Damian ;   et al. | 2021-03-18 |
Novel Rna-programmable Endonuclease Systems And Uses Thereof App 20210054353 - COHNEN; Andre ;   et al. | 2021-02-25 |
Novel Rna-programmable Endonuclease Systems And Their Use In Genome Editing And Other Applications App 20200385720 - COHNEN; Andre ;   et al. | 2020-12-10 |
Hppd Variants And Methods Of Use App 20200239905 - Linka; Marc ;   et al. | 2020-07-30 |
HPPD variants and methods of use Grant 10,597,674 - Linka , et al. | 2020-03-24 |
Hppd Variants And Methods Of Use App 20200063155 - Linka; Marc ;   et al. | 2020-02-27 |
Site Specific Homogeneous With Ksp Inhibitors App 20190262463 - LERCHEN; Hans-Georg ;   et al. | 2019-08-29 |
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) Grant RE47,150 - Wang , et al. De | 2018-12-04 |
Hppd Variants And Methods Of Use App 20180208937 - Linka; Marc ;   et al. | 2018-07-26 |
Anti-c4.4a Antibodies And Uses Thereof App 20170158775 - LINDEN; Lars ;   et al. | 2017-06-08 |
Humanized monoclonal antibodies against activated protein C and uses thereof Grant 9,657,111 - Zhao , et al. May 23, 2 | 2017-05-23 |
Antibodies to TNF.alpha. Grant 9,534,046 - Votsmeier , et al. January 3, 2 | 2017-01-03 |
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) Grant 9,309,324 - Wang , et al. April 12, 2 | 2016-04-12 |
Antibodies to TNF Alpha App 20150329629 - Votsmeier; Christian ;   et al. | 2015-11-19 |
Humanized Monoclonal Antibodies Against Activated Protein C And Uses Thereof App 20150322164 - ZHAO; Xiao-Yan ;   et al. | 2015-11-12 |
Anti-FGFR2 Antibodies and Uses Thereof App 20140322220 - Harrenga; Axel ;   et al. | 2014-10-30 |
Antibodies to TNF Alpha App 20130230886 - Votsmeier; Christian ;   et al. | 2013-09-05 |
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) Grant 8,481,030 - Wang , et al. July 9, 2 | 2013-07-09 |
Antibodies to TNF.alpha. Grant 8,399,627 - Votsmeier , et al. March 19, 2 | 2013-03-19 |
Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) App 20120329996 - Wang; Zhuozhi ;   et al. | 2012-12-27 |
Anti-c4.4a Antibodies And Uses Thereof App 20120321619 - Linden; Lars ;   et al. | 2012-12-20 |
Protease Variants App 20120237496 - Birkenfeld; Joerg ;   et al. | 2012-09-20 |
Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) App 20120108796 - WANG; Zhuozhi ;   et al. | 2012-05-03 |
Antibodies to TNF Alpha App 20100297700 - Votsmeier; Christian ;   et al. | 2010-11-25 |
Process For Generating Sequence-specified Proteases By Directed Evolution And Use Thereof App 20080160558 - KOLTERMANN; ANDRE ;   et al. | 2008-07-03 |
Serine proteases with altered sensitivity to activity-modulating substances App 20060269538 - Koltermann; Andre ;   et al. | 2006-11-30 |
Process for generating sequence-specific proteases by directed evolution and use thereof App 20040072276 - Koltermann, Andre ;   et al. | 2004-04-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.